Rb targets histone H3 methylation and HP1 to promoters (original) (raw)

Nature volume 412, pages 561–565 (2001)Cite this article

Abstract

In eukaryotic cells the histone methylase SUV39H1 and the methyl-lysine binding protein HP1 functionally interact to repress transcription at heterochromatic sites1. Lysine 9 of histone H3 is methylated by SUV39H1 (ref. 2), creating a binding site for the chromo domain of HP1 (refs 3, 4). Here we show that SUV39H1 and HP1 are both involved in the repressive functions of the retinoblastoma (Rb) protein. Rb associates with SUV39H1 and HP1 in vivo by means of its pocket domain. SUV39H1 cooperates with Rb to repress the cyclin E promoter, and in fibroblasts that are disrupted for SUV39, the activity of the cyclin E and cyclin A2 genes are specifically elevated. Chromatin immunoprecipitations show that Rb is necessary to direct methylation of histone H3, and is necessary for binding of HP1 to the cyclin E promoter. These results indicate that the SUV39H1–HP1 complex is not only involved in heterochromatic silencing but also has a role in repression of euchromatic genes by Rb and perhaps other co-repressor proteins.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 51 print issues and online access

$199.00 per year

only $3.90 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Jones, D. O., Cowell, I. G. & Singh, P. B. Mammalian chromodomain proteins: their role in genome organisation and expression. BioEssays 22, 124–137 (2000).
    Article CAS Google Scholar
  2. Rea, S. et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 406, 593–599 (2000).
    Article ADS CAS Google Scholar
  3. Bannister, A. J. et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 410, 120–124 (2001).
    Article ADS CAS Google Scholar
  4. Lachner, M., O'Carroll, D., Rea, S., Mechtler, K. & Jenuwein, T. Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins. Nature 410, 120–124 (2001).
    Article ADS Google Scholar
  5. Brehm, A. et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597–601 (1998).
    Article ADS CAS Google Scholar
  6. Magnaghi-Jaulin, L. et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601–605 (1998).
    Article ADS CAS Google Scholar
  7. Luo, R. X., Postigo, A. A. & Dean, D. C. Rb interacts with histone deacetylase to repress transcription. Cell 92, 463–473 (1998).
    Article CAS Google Scholar
  8. Firestein, R., Cui, X., Huie, P. & Cleary, M. L. Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9. Mol. Cell. Biol. 20, 4900–4909 (2000).
    Article CAS Google Scholar
  9. Hurford, R. K. Jr, Cobrinik, D., Lee, M. & Dyson, N. pRB and p107/p130 are required for regulated expression of different sets of E2F responsive genes. Genes Dev. 11, 1447–1463 (1997).
    Article CAS Google Scholar
  10. Herrera, R. E. et al. Altered cell cycle kinetics, gene expression and G1 restriction point regulation in Rb deficient fibroblasts. Mol. Cell. Biol. 16, 2402–2407 (1996).
    Article CAS Google Scholar
  11. Aagaard, L. et al. Functional mammalian homologues of the Drosophila PEV-modifier Su(var)3-9 encode centromere-associated proteins which complex with the heterochromatin component M31. EMBO J. 18, 1923–1938 (1999).
    Article CAS Google Scholar
  12. Williams, L. & Grafi, G. The retinoblastoma protein—a bridge to heterochromatin. Trends Plant Sci. 5, 239–240 (2000).
    Article CAS Google Scholar
  13. Korner, K. & Muller, R. J. In vivo structure of the cell cycle-regulated human cdc25C promoter. Biol. Chem. 275, 18676–18681 (2000).
    Article CAS Google Scholar
  14. Hagemeier, C., Cook, A. & Kouzarides, T. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21, 4998–5004 (1993).
    Article CAS Google Scholar
  15. Qin, X. Q., Chittenden, T., Livingston, D. M. & Kaelin, W. G. Jr Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6, 953–964 (1992).
    Article CAS Google Scholar
  16. Bannister, A. J. & Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature 384, 641–643 (1996).
    Article ADS CAS Google Scholar
  17. Nielsen, A. L. et al. Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family. EMBO J. 18, 6385–6395 (1999).
    Article CAS Google Scholar
  18. Orlando, V., Strutt, H. & Paro, R. Analysis of chromatin structure by in vivo formaldehyde cross-linking. Methods 11, 205–214 (1997).
    Article CAS Google Scholar
  19. Dedon, P. C., Soults, J. A., Allis, C. D. & Gorovsky, M. A. A simplified formaldehyde fixation and immunopreciptation technique for studying protein–DNA interactions. Anal. Biochem. 197, 83–90 (1991).
    Article CAS Google Scholar

Download references

Acknowledgements

We thank M. Weldon for Edman degradation of labelled proteins; H. Herschman for providing GAR; R. Laskey for the anti-HP1 antibody; and A. Cook for technical assistance. S.J.N. and A.J.B. were funded by a grant from the Cancer Research Campaign, R.S. by an EC grant and an EMBO fellowship, and U.M.B. by an HFSP grant.

Author information

Author notes

  1. Soren J. Nielsen, Robert Schneider, Ron Firestein and Michael Cleary: These authors have contributed equally to this work.

Authors and Affiliations

  1. Wellcome/CRC Institute and Department of Pathology, Tennis Court Road, Cambridge, CB2 1QR, UK
    Soren J. Nielsen, Robert Schneider, Uta-Maria Bauer, Andrew J. Bannister & Tony Kouzarides
  2. Department of Molecular and Cellular Biology, Baylor College of Medicine, The Breast Center, 1 Baylor Plaza, Houston, 77030, Texas, USA
    Ashby Morrison & Rafael E. Herrera
  3. Research Institute of Molecular Pathology (IMP), The Vienna Biocenter, Dr. Bohrgasse 7, Vienna, A-1030, Austria
    Donal O'Carroll & Thomas Jenuwein
  4. Department of Pathology, Stanford University Medical Center, Stanford, 94305, California, USA
    Ron Firestein & Michael Cleary

Authors

  1. Soren J. Nielsen
    You can also search for this author inPubMed Google Scholar
  2. Robert Schneider
    You can also search for this author inPubMed Google Scholar
  3. Uta-Maria Bauer
    You can also search for this author inPubMed Google Scholar
  4. Andrew J. Bannister
    You can also search for this author inPubMed Google Scholar
  5. Ashby Morrison
    You can also search for this author inPubMed Google Scholar
  6. Donal O'Carroll
    You can also search for this author inPubMed Google Scholar
  7. Ron Firestein
    You can also search for this author inPubMed Google Scholar
  8. Michael Cleary
    You can also search for this author inPubMed Google Scholar
  9. Thomas Jenuwein
    You can also search for this author inPubMed Google Scholar
  10. Rafael E. Herrera
    You can also search for this author inPubMed Google Scholar
  11. Tony Kouzarides
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toTony Kouzarides.

Rights and permissions

About this article

Cite this article

Nielsen, S., Schneider, R., Bauer, UM. et al. Rb targets histone H3 methylation and HP1 to promoters.Nature 412, 561–565 (2001). https://doi.org/10.1038/35087620

Download citation

This article is cited by

Associated content